We were extremely thrilled to launch the project Bacter-EV-Booster (~3.5 M€) funded by France2030. In this project coordinated by Jean-Marc Chatel (INRAE) and Amanda Silva Brun (CNRS, Univ. Paris Cité), our consortium will focus on innovative bioproduction to facilitate biotherapy democratization.
© Tous droits réservés
We will rely on a multidisciplinary approach to stimulate the bioproduction and bio-engineering of bacteria’s Extracellular Vesicles (EVs) for treating diseases related to gut inflammation and the gut-brain axis. Bacter-EV-Booster is funded in the frame of the PEPR program Biotherapies and Bioproduction of Innovative Therapies (BBiT).